CannTrust Holdings Inc CNTTQ

just received this

[Growth400]

CannTrust Cannabis Products to be Available to NexgenRx Sponsors and Health Plan Members Published by NCV Newswire NexgenRx and CannTrust Partner to Provide Medical Cannabis Benefit Access and Real Time Adjudication Services to NexgenRx Plan Members May 01, 2018 Toronto, Ontario (FSCwire) NEXGENRX INC. (NexgenRx or the Company, TSX-V: NXG) is pleased to announce that it has signed an exclusive agreement with CannTrust Inc. (CannTrust), one of Canadas leading licensed producers of medical cannabis and a wholly-owned subsidiary of CannTrust Holdings Inc. (CannTrust, TSX: TRST), to create a simple, seamless ordering process for NexgenRx plan members. The agreement is for an initial five (5) year renewable term. CannTrust offers NexgenRx plan sponsors and plan members (i.e.patients) the broadest range of industry leading, high quality, standardized medical cannabis products. CannTrust, a pharmacist-led, innovative organization, continues to develop new formats to deliver safe and convenient dosage forms for its patients. With the recent launch of CannTrusts hard shell vegan capsules, patients now have multiple safe and easy-to-administer familiar dosage formats of medical cannabis. NexgenRx will be offering plan sponsors who desire access to these products for their plan members a physician controlled, prescription process. With this agreement, NexgenRx plan members will now be able to order their medical cannabis products from CannTrust and have a portion of their prescription covered, calculated and applied in real-time by their health care benefits plan. NexgenRxs compliance tracking and a sophisticated drug utilization review (DUR) process will provide clinical scrutiny as part of the adjudication approval process. At check-out, NexgenRx plan members will only be required to pay the amount not covered by their plan. This real-time adjudication creates a smooth and convenient process for patients, a first of its kind for the medical cannabis market